Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge - PubMed (original) (raw)

Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge

E J Stott et al. J Virol. 1986 Nov.

Abstract

Recombinant vaccinia virus vectors were constructed which expressed the major surface glycoprotein G of human respiratory syncytial (RS) virus. The biological activity of the G protein expressed from these vectors was assayed. Inoculation of rabbits with live recombinant virus induced high titers of antibody which specifically immunoprecipitated RS virus G protein and was capable of neutralizing RS virus infectivity. Immunization of mice by either the intranasal or the intraperitoneal route with recombinant virus that expressed only the G protein resulted in complete protection of the lower respiratory tract upon subsequent challenge with live RS virus.

PubMed Disclaimer

References

1. 1. Am J Epidemiol. 1969 Apr;89(4):422-34 - PubMed
2. 1. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1906-10 - PubMed
3. 1. Am J Pathol. 1978 Dec;93(3):771-91 - PubMed
4. 1. Virology. 1979 May;95(1):137-45 - PubMed
5. 1. Methods Enzymol. 1980;65(1):499-560 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information